This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Cramer's 'Mad Money' Recap: Europe's Problems a Global Problem

Cramer said for investors who are bullish on the American consumer, Lithia is the perfect speculative stock. Lithia is domestic and it's in a fragmented market with tons of room to grow.

In its most recent quarter, Lithia increased its same-store sales by a stellar 22%, with new car sales growing by 25%. Compare that to the next closest competitor, Sonic Automotive (SAH), which only grew by 12.1%. In addition to sales, Lithia has great margins and is taking market share from its rivals.

Cramer said Lithia clearly knows what works and offers not only sales, but service, financing and insurance, three services with high margins and steady income streams. Service alone accounts for 32% of Lithia's profits.

Despite beating Wall Street expectations by 18 cents a share, Lithia remains the cheapest of all the auto dealership stocks, said Cramer.

But as great as Lithia may be, Cramer said he still cannot recommend the stock given the weak unemployment data received today. Consumers stopped buying cars before, he said, and they may stop again. For investors who are bullish on American growth however, Lithia "may be the stock for you."

Circling the Wagons

In a terrible market, it pays to circle the wagons around recession-resistant company you can count on, Cramer said. Investors can't just invest for today, they must invest in the bargains that are being created, the stocks with high yields that will snap back quickly.

That's why Cramer recommended Johnson & Johnson, a once-hated company that now sports a new CEO and a 4% dividend yield. Cramer said that J&J is now a potential breakup story as the company is actually three businesses in one.

According to a recent research report, J&J could split itself into a pharmaceutical company, a consumer products company and a medical devices company, thus unlocking $76 a share worth of value, a 23% premium from today prices. Breakups in health care work, Cramer reminded viewers, as evidenced by Abbott Labs (ABT), another Action Alerts PLUS holding, as well as Pfizer (PFE) and Covidian (COV).

But even without a breakup, Cramer said he's a believer in new CEO Alex Gorsky. He said a fresh set of eyes can do wonders at a company and Gorsky, a long-time J&J employee, will know his way around. Unlike other drug makers, Johnson & Johnson is largely past its wave of patent expirations, said Cramer, and the company has a slew of new drugs set to power future growth.

2 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
ED $61.14 -1.90%
JNJ $101.43 -1.10%
LAD $91.97 -0.38%
AAPL $128.63 1.80%
FB $80.50 -0.87%


DOW 18,057.28 -78.44 -0.43%
S&P 500 2,096.02 -5.02 -0.24%
NASDAQ 4,969.3870 -13.4220 -0.27%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs